CRECIENTES SEÑALES DE PROBLEMAS DE LIQUIDEZ ENTRE LOS GRANDES BANCOS EN USA Y UK (JustDario, 6-10-2024)

 As a matter of fact, since the JPY Carry Trade forced unwinding started to bite, the BOE has been busy injecting liquidity into the system (THE JPY CARRY TRADE IMPLOSION CONTAGION IS ALREADY SPREADING INTO THE UK) with the BOE Short term repo OMO growing from zero to ~40m GBP in a few months till now. 

 

Please have a look at the chart below from 2022 to 2023 (when the latest banking crisis surfaced in all its beauty). As you can easily notice, while large banks’ deposits only decreased slightly overall (likely the reason why it took a while for the MSM and furus to realize a crisis was brewing), cash held at large US commercial banks part of the Federal Reserve system was collapsing in a clear sign of a liquidity crisis.

 

You can see the situation started to improve exactly at the moment the FED BTFP became operational, so no, the problems were not only within US regional banks contrary to what all the Central Bankers, Nobel prizes, and public officials were claiming. Credit Suisse’s emergency bailout was another proof of that, but still greatly ignored.

 Now, please have a look at what’s happening today despite Jerome Burns just declaring the FED cut rates by 50bp despite everything being awesome in the economy and in the financial system

 

What’s even more interesting is that Cash is being moved from Large to Small banks in equal proportions even if there has not been a similar shift in deposits. What does this mean? Clearly, customers still trust large banks, but clearly, smaller bank treasurers aren’t trusting them in the same way and are shifting cash back into their books.

 

 

At this point, I hope we all agree there are liquidity issues within Large US Banks with Bank of America the number one suspect at the moment. Why? Here is what I warned about two months ago and since then Warren Buffett sold $8bn USD worth of BAC shares and is just 0.1% away from going below the 10% ownership threshold after which he will not be required to inform the market promptly of any further sale (so likely he is going to cut his stake at a faster pace)

Putting all together, it is undeniable that there are increasing liquidity issues in both the US and the UK, but no worries next Friday when banks start reporting there will be little chance that they will confirm this to the public. Especially Bank of America which is expected to report its Q3-2024 on the 15th of October. Furthermore, we are one month away from US elections so do not expect the SEC or the FED to take any action to tackle this problem because the political embarrassment for the incumbent US administration seeking re-election will significantly undermine their effort to make everything look awesome in both the economy and the financial system. Personally, I do not expect a 2008-style “Lehman moment” before elections either, but there is always a small probability that things go out of control all of a sudden if fears quickly spread among financial institutions.

 

 

MOUNTING SIGNS OF LIQUIDITY PROBLEMS AMONG LARGE US AND UK BANKS

EL TRIBUNAL SUPREMO (USA) DECIDE EN FAVOR DE TWITTER, GOOGLE Y FACEBOOK (RESPONSABILIDAD POR CONTENIDO DE USUARIOS)

The Supreme Court unanimously sided with Twitter, Google, and Facebook, finding in a pair of decisions on May 18 that the Silicon Valley giants are shielded from liability for content posted by users. 

 

The lawsuits arose after deadly Islamic terrorist attacks overseas. Victims’ families argued that the Big Tech companies were liable because they allowed terrorist videos to be posted online or failed to do enough to police the terrorist accounts posting the videos. 

 

 Big Tech and its supporters had been deeply concerned that the court could eviscerate Section 230 of the federal Communications Decency Act of 1996, which generally prevents internet platforms and internet service providers from being held liable for what users say on them. They say the legal provision, sometimes called “the 26 words that created the internet,” has fostered a climate online in which free speech has flourished.

 

 The Supreme Court’s new 38-page decision (pdf) in Twitter Inc. v. Taamneh, court file 21-1496, was written by Justice Clarence Thomas.

 

 

 

 

Twitter, Inc. v. Taamneh https://t.co/F6lFkTJtuR
Holding: Plaintiffs’ allegations that the social-media-company defendants aided and abetted ISIS in its terrorist attack on a nightclub in Instanbul, Turkey fail to state a claim under 18 U.S.C. § 2333(d)(2)#SCOTUS

— Guillermo Ruiz Zapatero (@ruiz_zapatero) May 19, 2023

PETICIÓN A LA FDA (USA) PARA EL "REETIQUETADO" DE VACUNAS COVID-19 (31-01-2023)

Important Citizen Petition to FDA, signed by prominent academics calls for immediate update of COV19 vac’s labels. No proof re efficacy against infection & transmission, serious AEs like CA, impact on fertility & holding back data re impact on pregnancy. https://t.co/N9S4aJBhNg pic.twitter.com/CkZ9FtQOrr

— Retsef Levi (@RetsefL) February 3, 2023

 

 

To request that the Commissioner of Food and Drugs (the “Commissioner”) require that the sponsors of Comirnaty, Spikevax, Pfizer-BioNTech COVID-19 Vaccine, and Moderna COVID-19 Vaccine (collectively, “Pfizer and Moderna COVID-19 vaccines”) amend current product labeling.

Incomplete, inaccurate, or misleading labeling of any medical product can negatively impact the health and safety of Americans, with global ramifications considering the international importance of FDA decisions. For these reasons, and due to the compelling need to ensure the safety and efficacy of any COVID-19 vaccine licensed by the FDA and to allow Petitioner the opportunity to seek emergency judicial relief should the instant Petition be denied, it is respectfully requested that FDA act on the instant Petition by April 30, 2023.

I. ACTIONS REQUESTED
Petitioner requests that the FDA amend current labelingi of Pfizer and Moderna COVID-19 vaccines (for all authorized or approved indications and populations) in the following ways:

1. Add language clarifying that phase III trials were not designed to determine and failed to provide substantial evidence of vaccine efficacy against SARS-CoV-2 transmission or death.

2. Add language clarifying that the immunobridging surrogate endpoint used in multiple authorized indications has not been validated to predict clinical efficacy.

 3. Add safety and efficacy results data from manufacturer randomized trials of current bivalent boosters that reported results after EUA was granted.

4. Add a clear statement that FDA authorized a new Pfizer vaccine formulation containing Tris buffer without requiring clinical studies to evaluate efficacy, safety or bioequivalence to the formulation containing phosphate buffer.

5. Add a clear statement disclosing that a Pfizer phase III randomized trial in pregnant women (NCT04754594) was completed as of July 2022 but there have been no results reported.

6. Add a clear statement that Pfizer vaccine efficacy wanes after 2 months following dose 2 according to the Pfizer phase III randomized trial.

7. The following adverse event types should be added to the Adverse Reactions section of labeling:
a. multisystem inflammatory syndrome (MIS) in children;
b. pulmonary embolism;
c. sudden cardiac death;
d. neuropathic and autonomic disorders.

8. The following reproductive health and lactation related adverse event types should be added to the Adverse Reactions section of labeling:
a. decreased sperm concentration;
b. heavy menstrual bleeding;
c. detection of vaccine mRNA in breastmilk.

9. Add frequency data for clinical and subclinical myocarditis.

10. Labeling should present trial results on serious adverse events in tables with statistics, as is done for non-serious adverse events.

Petitioner also requests the FDA create a Medication Guide and communicate these labeling changes via a Dear Health Care Provider (DHCP) letter.

UNA PROPOSICIÓN DE LEY (USA) PARA ELIMINAR LA AUSENCIA DE RESPONSABILIDAD POR LOS DAÑOS DE LAS VACUNAS COVID (I)

 

 A BILL

To amend titles III and XXI of the Public Health Service
Act to hold vaccine manufacturers liable for injuries
caused by vaccines subject to a public mandate, and
for other purposes.
1 Be it enacted by the Senate and House of Representa2
tives of the United States of America in Congress assembled,
3 SECTION 1. MANDATED VACCINE MANUFACTURER LIABIL

4ITY.
5 (a) PANDEMIC AND ENDEMIC PRODUCTS.—Section
6 319F–3(d) of the Public Health Service Act (42 U.S.C.
7 247d–6d(d)) is amended—

(...)

‘‘(2) VACCINES.—The immunity from suit and
9 liability of covered persons set forth in subsection
10 (a) shall not apply with respect to the administration
11 of a vaccine licensed under section 351 or authorized
12 for emergency use under section 564 of the Federal
13 Food, Drug, and Cosmetic Act if any agency of the
14 Federal Government, any official of the Government,
15 any agency of any State government, any official of
16 any state government, or any entity that receives
17 Federal or State funding, either directly or indi

18rectly, requires the administration of such vaccine or
19 provides for any penalty or loss of privileges for the
20 refusal to consent to administration of such vac

21
cine.’’.

 
22 (b) VACCINE INJURY COMPENSATION PROGRAM.—
23 Section 2111(a)(2) of the Public Health Service Act (42
24 U.S.C. 300aa–11(a)(2)) is amended—

16 (c) VACCINE INJURY TABLE.—Section 2114(c) of the
17 Public Health Service Act (42 U.S.C. 300aa–14(c)) is
18 amended—
19 (1) in paragraph (1), by inserting ‘‘and subject
20 to paragraph (5)’’ after ‘‘paragraph (3)’’; and
21 (2) by adding at the end the following:
22 ‘‘(5) Beginning on the date of the enactment of this
23 paragraph, the Secretary may not add a vaccine to the
24 Vaccine Injury Table if —

1 ‘‘(A) the administration of such vaccine is re

2quired by any agency of the Federal Government,
3 any official of the Government, or any entity that re4
ceives Federal funding, either directly or indirectly;
5 and
6 ‘‘(B) the vaccine was administered—

7 ‘‘(i) without first obtaining from the per

8son receiving the vaccine the informed consent
9 of that person; or

10 ‘‘(ii) without such person being provided a
11 religious or medical exemption if a request was
12 made for such an exemption.’’

Rep. Gohmert Introduces Bill to hold Big Pharma Liable for Injuries Caused by Publicly Mandated Vaccines

 Rep. Louie Gohmert (TX-01) released the following statement after introducing a bill to eliminate liability protection for companies when their vaccines are subject to public mandates:

“The immense human suffering our country experienced due to the disgraceful COVID-19 vaccine mandates must never happen again,” said Rep. Gohmert. “Through their reckless edict, the Biden Administration forced many Americans to choose between maintaining their livelihoods and protecting their bodily autonomy from an experimental vaccine—one that we now have come to learn does not protect against infection or transmission. Even more important than the financial ruin the mandates have caused to so many Americans are the clear and present dangers these vaccines can pose to the health and safety of those who have received it. 

“If the United States government wishes to force Americans to take an experimental vaccine, the U.S. Constitution and human rights norms dictate that it must make the case and convince Americans that it is safe and effective, respecting informed consent and the right to refuse.  If the U.S. government refuses to honor even the most basic individual right in such matters, then no reasonable person would argue that there should also be immunity from liability for the very products being forced into the populace.  This bill would rightly eliminate liability protection for pharmaceutical manufacturers for any vaccine subject to a mandate. It is time pharmaceutical companies stand behind their products and face accountability when necessary.”

 

 

LA CRISIS FINANCIERA EN USA, EUROPA Y JAPON (ALASDAIR MACLEOD)

LEY DE PREPARACIÓN Y ACTUACIÓN PÚBLICA DE EMERGENCIA (USA) Y EXENCIÓN DE RESPONSABILIDAD DE LOS FABRICANTES

EL SENADOR HALL (TEXAS) SOBRE LA AUSENCIA DE RESPONSABILIDAD DE LOS FABRICANTES Y LOS MANDATOS DE VACUNACIÓN

 

Tulio Campregher

@tttulio

7h

Replying to

@NeverSleever

So the only ones getting complete immunity out of the vaccines are the pharma companies

LA DEFINICIÓN CIRCULAR DE VACUNACIÓN Y VACUNA

EL TESTIMONIO DEL DR. STEVEN QUAY ANTE EL CONGRESO AMERICANO SOBRE EL ORIGEN DEL COVID-19

At today's GOP House Oversight and Reform Subcommittee on Select Coronavirus Crisis hearing, GOP-called witnesses Dr. Steven Quay and Dr. Richard Muller said that within the COVID-19 virus were indications that it was created through gain-of-function research.

EDWARD McCAFFERY: LA MUERTE DEL IMPUESTO SOBRE LA RENTA

VACUNAS GENÉTICAS Y SISTEMA DE INFORMACIÓN DE SUCESOS DE VACUNACIÓN ADVERSOS (III)

SISTEMA DE INFORMACIÓN DE SUCESOS DE VACUNACIÓN ADVERSOS (II)

SISTEMA DE INFORMACIÓN DE SUCESOS DE VACUNACIÓN ADVERSOS (I)

EL INFORME SOBRE EL ORIGEN DEL COVID-19 CONSIDERADO POR EL SENADO USA

LA FINANCIACIÓN AMERICANA DEL LABORATORIO DE WUHAN

LA "EPOPEYA" DEL ESTADO ADMINISTRATIVO Y LAS ELECCIONES PRESIDENCIALES AMERICANAS (I)

LAS DECLARACIONES FALSAS DE DONALD TRUMP SOBRE LOS RESULTADOS ELECTORALES (II)

LAS DECLARACIONES FALSAS DE DONALD TRUMP SOBRE LOS RESULTADOS ELECTORALES (I)

EL INFORME DEL CONGRESO USA SOBRE ABUSO DE DOMINIO EN LOS MERCADOS DIGITALES Y REMEDIOS CONTRA EL MISMO

JUSTICIA TRIBUTARIA